MACRO GROUP PHARMACEUTICALS (MACRO CAPITAL) S.A.E |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.13 EGP | +3.40% |
|
-1.84% | -27.80% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 730M 15.57M | Sales 2023 | 526M 11.22M | Capitalization | 1.68B 35.9M |
|---|---|---|---|---|---|
| Net income 2022 | 174M 3.71M | Net income 2023 | -273M -5.83M | EV / Sales 2022 | 2.59 x |
| Net Debt 2022 | 16.96M 362K | Net Debt 2023 | 151M 3.22M | EV / Sales 2023 | 3.48 x |
| P/E ratio 2022 |
10.9
x | P/E ratio 2023 |
-6.1
x | Employees | - |
| Yield 2022 |
3.25% | Yield 2023 |
-
| Free-Float | 27.02% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.40% | ||
| 1 week | -1.84% | ||
| Current month | +2.40% | ||
| 1 month | -22.26% | ||
| 3 months | -32.17% | ||
| 6 months | -14.46% | ||
| Current year | -27.80% |
1 week
2.06
2.20
1 month
2.032.70
Current year
2.033.84
1 year
2.033.84
3 years
2.035.28
5 years
2.035.28
10 years
2.035.28
| Managers | Title | Age | Since |
|---|---|---|---|
Hisham Wasfy
CEO | Chief Executive Officer | - | 19-11-30 |
Ashraf Hamdy
DFI | Director of Finance/CFO | - | 19-06-30 |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sahar El-Sallab
BRD | Director/Board Member | - | 20-12-31 |
Ahmed Badreldin
BRD | Director/Board Member | 52 | 20-12-31 |
Ahmed El-Nayeb
FOU | Founder | - | 01-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-16 | 2.13 | +3.40% | 1,464,074 |
| 24-05-15 | 2.06 | -0.96% | 2,554,733 |
| 24-05-14 | 2.08 | -1.42% | 989,401 |
| 24-05-13 | 2.11 | 0.00% | 775,556 |
| 24-05-12 | 2.11 | -2.76% | 467,369 |
End-of-day quote Egyptian Exchange, May 15, 2024
More quotes
Macro Group Pharmaceutical S.A.E. (Macro Capital) is specialized in developing, manufacturing and marketing pharmaceuticals. The company's products include anti-scar, skincare, antiseptic, hair care, oral care and muscle relaxant medicines. In addition, the group offers plant-based medicines.
At the end of 2021, Macro Group Pharmaceutical S.A.E. (Macro Capital) had one production site in Egypt.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.13
EGP
Average target price
5.3
EGP
Spread / Average Target
+148.83%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -27.80% | 24.77M | |
| +32.36% | 709B | |
| +30.77% | 595B | |
| -1.60% | 367B | |
| +20.07% | 334B | |
| +6.04% | 289B | |
| +14.77% | 239B | |
| +9.13% | 211B | |
| -3.97% | 203B | |
| +9.27% | 171B |
- Stock Market
- Equities
- MCRO Stock
